PRESS RELEASE published on 06/19/2026 at 13:54, 2 months ago Agenda items receive broad approval at the annual general meeting; Jan Oberbeck re-elected to the Supervisory Board SURTECO GROUP SE's agenda items received broad approval at the annual general meeting, with Jan Oberbeck re-elected to the Supervisory Board. The company reported on sales and earnings performance in 2025 and expectations for 2026 Annual General Meeting Earnings SURTECO GROUP SE Sales Performance 2026 Outlook
PRESS RELEASE published on 06/19/2026 at 13:21, 2 months ago Forge Global Expands Investment Opportunities For Ripple Pre-IPO Shares San Francisco, California, June 19th, 2026, FinanceWire
PRESS RELEASE published on 06/19/2026 at 13:13, 2 months ago [Communiqué de presse] Le Groupe iliad renforce sa solidité financière avec 10 milliards d’euros de financement sécurisés et une amélioration de sa notation Moody’s Le Groupe iliad renforce sa solidité financière avec 10 milliards d’euros de financement sécurisés et améliore sa notation Moody’s. Opérations témoignant de la confiance des partenaires financiers et de la qualité des perspectives de développement Développement Partenaires Financiers Groupe Iliad Financement Sécurisé Amélioration Notation
PRESS RELEASE published on 06/19/2026 at 12:33, 2 months ago IUX Releases Educational Analysis on How Economic Volatility May Influence Force Sell Risk in Leveraged Trading Ebene Cybercity, Mauritius, June 19th, 2026, FinanceWire
PRESS RELEASE published on 06/19/2026 at 12:31, 2 months ago Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Sanofi's Sarclisa subcutaneous formulation approved in Japan for multiple myeloma patients, offering a convenient treatment option via OBI administration and manual injection Japan Sanofi Multiple Myeloma Sarclisa Subcutaneous Formulation
PRESS RELEASE published on 06/19/2026 at 12:31, 2 months ago Communiqué de presse : Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple Sanofi obtient l'approbation japonaise pour Sarclisa SC, traitement sous-cutané du myélome multiple, offrant commodité et efficacité. Possibilité d'administration via injecteur portable Japon Sanofi Myélome Multiple Approbation Sarclisa
PRESS RELEASE published on 06/19/2026 at 12:20, 2 months ago CGTN: China, Myanmar agree to deepen pragmatic cooperation across the board China and Myanmar strengthen pragmatic cooperation across various sectors, consolidating their friendship with cooperation agreements. Bilateral trade flourishing with major infrastructure projects underway China Coopération Infrastructure Projects Myanmar Bilateral Trade
PRESS RELEASE published on 06/19/2026 at 12:06, 2 months ago Schaeffler and Delair scale European drone production Schaeffler and Delair enter strategic partnership to scale European drone production, aiming to deliver 100 units/day by November 2026, combining world-class capabilities with expertise in design and deployment Strategic Partnership Europe Schaeffler Drone Production Delair
PRESS RELEASE published on 06/19/2026 at 11:47, 2 months ago Fuller, Smith & Turner PLC: TR-1: Standard form for notification of major holdings Fuller, Smith & Turner PLC announces Dunarden Limited's notification of major holdings. Non-UK issuer with 3.15% voting rights on 18/6/2026 Voting Rights Major Holdings Notification Fuller Smith Turner PLC Dunarden Limited
PRESS RELEASE published on 06/19/2026 at 11:30, 2 months ago Ottobock sells its Human Mobility wheelchair business Ottobock SE & Co. KGaA sells its Human Mobility wheelchair business to DHCare, focusing on core areas for growth. Transaction expected to close in H2/2026 Strategic Focus MedTech Ottobock DHCare Wheelchair Business
Published on 08/20/2026 at 02:22, 3 hours 40 minutes ago Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 00:40, 5 hours 22 minutes ago Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 8 hours 2 minutes ago Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 9 hours 27 minutes ago Revive Therapeutics Announces Proposed Shares for Debt Settlement
Published on 08/20/2026 at 04:10, 1 hour 52 minutes ago Shanghai Electric Contributes to World-record Biomethanol Bunkering Operation
Published on 08/20/2026 at 02:44, 3 hours 17 minutes ago Quarterly Report for Q2 and Interim Consolidated Financial Statements with Notes for the period from 1 January to 30 June 2026.
Published on 08/20/2026 at 01:45, 4 hours 17 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 Annual results – Delivers on guidance and progresses key strategic actions
Published on 08/18/2026 at 18:00, 1 day 12 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 12 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 18 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 18 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 10 hours ago Aéroports de Paris S.A - July 2026 traffic figures